Bicycle Therapeutics

NASDAQ: BCYC · Real-Time Price · USD
7.45
0.07 (0.95%)
At close: Aug 15, 2025, 3:59 PM
7.98
7.11%
After-hours: Aug 15, 2025, 07:33 PM EDT

Bicycle Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-243.12M -204.02M -169.58M -166.83M -165.4M -168.15M -180.66M -161.54M -139.99M -124.22M -112.72M -100.78M -87.11M -78.19M -66.82M -66.22M -61.68M -55.88M
Depreciation & Amortization
7.2M 7.14M 7.16M 7.12M 6.64M 6.65M 6.55M 6.28M 5.85M 4.82M 3.69M 2.71M 1.78M 1.51M 1.41M 1.33M 1.33M 1.3M
Stock-Based Compensation
38.58M 38.4M 38.08M 35.56M 33.79M 32.72M 32.48M 30.2M 28.14M 25.62M 26.78M 24.24M 21.56M 18.46M 12.08M 10.65M 9.47M 8.21M
Other Working Capital
-35.38M -43.8M -55.98M -74.36M 30.01M 27.24M 44.15M 58.44M -22.55M -6.38M -248K 6.4M 39.13M 31.73M 42.3M 30.07M -6.57M -6.06M
Other Non-Cash Items
-1.6M -1.48M -1.41M 3.8M 1.07M 1.04M 1.04M 368.93K 365.93K 405.93K 438.93K 480K 516K 510K 468K 425K 300K 171K
Deferred Income Tax
-6.02M -5.8M -5.24M -4.49M 6.11M 4.65M 3.31M -1.38M -8.66M -7.08M -4.97M n/a n/a n/a n/a n/a 1K n/a
Change in Working Capital
-3.75M -14.88M -33.76M -77.82M -46.06M 38.05M 76.66M 82.43M 65.79M -5.68M 672K 7.11M 24.6M 30.23M 38.06M 32.83M -2.1M -6.46M
Operating Cash Flow
-208.72M -180.63M -164.76M -202.65M -163.85M -85.05M -60.63M -43.65M -48.49M -106.12M -86.11M -66.24M -38.65M -27.49M -14.79M -20.98M -52.68M -52.66M
Capital Expenditures
-1.91M -1.83M -1.24M -918K -985.13K -841.99K -2.93M -4.33M -6.81M -16.33M -18.99M -18.61M -15.79M -6.16M -2.03M -1.45M -1.37M -1.5M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-1.91M -1.83M -1.24M -918.13K -985.13K -841.99K -2.93M -4.33M -6.81M -16.33M -18.99M -18.61M -15.79M -6.16M -2.03M -1.45M -1.37M -1.5M
Debt Repayment
-32.14M -32.09M -32.05M -32.01M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 15M 15M 30M 30M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
83.73K 83.75K 83.91K -2.03M 272.35K 437.35K 439.35K 491K 511K 541K 989K 3.08M 5.97M 7.35M 7.18M 4.88M 1.55M -19K
Financial Cash Flow
-31.81M 518.01M 519.92M 520.11M 786.67M 249.18M 250.03M 255.53M 21.06M 8.96M 6.69M 191.47M 231.76M 247.12M 320.73M 131.81M 152.44M 136.9M
Net Cash Flow
-239.91M 335.98M 353.1M 318.77M 621.48M 163.73M 187.82M 211.16M -32.34M -113.56M -99.53M 101.94M 174.03M 211.47M 302.69M 109.68M 101.83M 86.26M
Free Cash Flow
-210.62M -182.46M -166M -203.57M -164.83M -85.89M -63.56M -47.98M -55.3M -122.45M -105.1M -84.84M -54.44M -33.65M -16.82M -22.42M -54.05M -54.16M